Aberrant cytoplasmic localization of MLH1 characterizes a sub-clonal breast cancer cell population that seeds recurrence
Aloran Mazumder, Jerry Tyler DeWitt, Elena Oropeza, Nindo B. Punturi, Daniel Lozano, Megha Raghunathan, Jonathan M. Piscitelli, Elham Sajjadi, Elena Guerini-Rocco, Konstantinos Venetis, Mariia D. Ivanova, Eltjona Mane, Marianna D’Ercole, Alberto Concardi, Nicola Fusco, , Svasti Haricharan
This study identifies aberrant cytoplasmic MLH1 localization in sub-clonal breast cancer cells as a driver of endocrine resistance, showing it predicts response to CDK4/6 inhibitors.
Nature Communications · Dec 10, 2025Peer-reviewedCancer Biology